Contrave Boosts Weight Loss for Breast Cancer Survivors
Breast cancer survivors who lost ≤5% of body weight with diet and exercise experienced greater weight loss, improved function, and less pain with Contrave.
Related Articles
The Nonlinear Association Between Catheterisation Duration and Urinary Tract Infection in Patients With Geriatric Hip Fracture: A Retrospective Study
Aim To rigorously examine the association between catheterisation duration and urinary tract infections among geriatric patients with hip fractures. Design Retrospective cohort study. Methods We…
How Cancer Treatment Can Increase Risk for Other Conditions in Survivors
Cancer treatments can speed up aging in survivors, according to research, which can contribute to a person’s risk for conditions like heart disease.
Utilizing AI Precision Medicine to Best Choose Prostate Cancer Therapy
A new AI precision medicine test is being used to help clinicians better identify a personalized treatment plan to treat patients with prostate cancer.
WAIT-UP SLT: Exploring Experiences of Waiting within Children’s Speech and Language Therapy – Evidence-Based Nursing blog
This week’s blog is written by PhD candidate, and Senior Lecturer, Gillian Rudd from Birmingham City University. Gill’s blog is about her PhD study…
FDA Grants Fast Track Designation to HLD-0915 in Prostate Cancer
The FDA has granted fast track designation to HLD-0915 for metastatic castration-resistant prostate cancer.
Breast Cancer Survivor Shares Benefits of Strength Training on Chemo
Breast cancer survivor and researcher LaShae Rolle studies how individualized strength training during chemo boosts physical, mental and emotional health.
Cylembio Plus Keytruda Extends PFS in Trial For Advanced Melanoma
Data show that the cancer vaccine Cylembio plus Keytruda demonstrated clinical improvement in progression-free survival in unresectable/advanced melanoma.
WAIT-UP SLT: Exploring Experiences of Waiting within Children’s Speech and Language Therapy – Evidence-Based Nursing blog
This week’s blog is written by PhD candidate, and Senior Lecturer, Gillian Rudd from Birmingham City University. Gill’s blog is about her PhD study…
Financial and Educational Disparities Persist in Glioblastoma Care
A nationwide survey of patients and caregivers has found educational and financial disparities in brain cancer care.
FDA Approval of Modeyso ‘Important Step Forward’ For Patients with Glioma
The accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation, is a step in the right direction but more work remains.